Arcadia Biosciences, Inc. (RKDA) — Analysis Summary
Arcadia Biosciences, Inc. (RKDA) has a market cap of $1.98M with year-over-year revenue growth of -3.7%. Net margin stands at -48.1%. The stock trades at a P/E ratio of -0.2.
Key Takeaways
- Revenue changed -3.7% year-over-year
- Net margin of -48.1%
- P/E ratio of -0.2
Compared to other companies in the CRUDE PETROLEUM & NATURAL GAS sector, RKDA posted revenue growth of -3.7% and trades at a P/E of -0.2.
Disclaimer: This is not financial advice. Data sourced from SEC EDGAR and Polygon.io. Past performance does not guarantee future results. Always conduct your own research before making investment decisions.